Literature DB >> 17844893

Management of comorbid diabetes and cancer.

Marybeth Singer1.   

Abstract

Diabetes mellitus is a frequent comorbidity of cancer patients. The growing epidemic of diabetes is anticipated to have tremendous impact on health care. Diabetes may negatively impact both cancer risk and outcomes of treatment. Oncology nurses are ideally positioned to identify patients at risk for complications that arise from cancer treatment in the setting of pre-existing diabetes. Additionally, oncology nurses may be the first to identify underlying hyperglycemia/hidden diabetes in a patient undergoing cancer treatment. Strategies for assessment and treatment will be discussed, along with specific strategies for managing hyperglycemia, potential renal toxicity, and peripheral neuropathy. Guidelines for aggressive treatment of hyperglycemia to minimize risks of complications will be reviewed. The role of interdisciplinary care, utilizing current evidence, is crucial to supporting patients and their families as they manage the challenges of facing two life-limiting diseases. Whole-person assessment and individualized treatment plans are key to maximizing quality of life for patients with cancer and diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17844893

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  3 in total

1.  Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.

Authors:  Abhijat Kitchlu; Eric McArthur; Eitan Amir; Christopher M Booth; Rinku Sutradhar; Habeeb Majeed; Danielle M Nash; Samuel A Silver; Amit X Garg; Christopher T Chan; S Joseph Kim; Ron Wald
Journal:  J Natl Cancer Inst       Date:  2019-07-01       Impact factor: 13.506

2.  Diabetes management and self-care education for hospitalized patients with cancer.

Authors:  Ashley Leak; Ellen D Davis; Laura B Houchin; Melanie Mabrey
Journal:  Clin J Oncol Nurs       Date:  2009-04       Impact factor: 1.027

3.  Moderating effects of sleep duration on diabetes risk among cancer survivors: analysis of the National Health Interview Survey in the USA.

Authors:  Azizi A Seixas; Lloyd Gyamfi; Valerie Newsome; Gabrielle Ranger-Murdock; Mark Butler; Diana Margot Rosenthal; Ferdinand Zizi; Irini Youssef; Samy I McFarlane; Girardin Jean-Louis
Journal:  Cancer Manag Res       Date:  2018-10-12       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.